Abstract
The recession has caused many companies to reconsider their corporate strategy
and research outlook. With the financial crisis, expansion through acquisition
has no longer been possible and companies have been forced to plan for organic
growth based on product efficiency, innovation, service and price.
Against a fragile and recovering economic backdrop, the key players in the
cardiovascular field are now emerging as leaner, stronger and more focused
entities that are exploring opportunities in biologics and other development
areas. M&A' s may grab the headlines but it is product portfolios that are
really beginning to excite and attract observers.
Now in its fourth year of publication, the latest 2009 release of Who' s
Developing What in Cardiovascular Devices? provides the ideal opportunity to
review the progress, and monitor the prospects, of both emerging and
established industry participants.
Key areas covered for each company include:
- Company Overview
- Key Personnel
- Key Milestones
- Competitor Analysis
- Products/Technologies R&D and Research Strategy
- Key Agreements and Alliances
- Financial Data
- Comprehensive Contact Details
Use this report to:
- Evaluate the competitive landscape and identify the companies to watch
- Know who' s striking strategic and tactical partnerships
- Identify for company areas of research areas and establish development
trends
| 
View Cart
